SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Net Equity Issued and Repurchased (2021 - 2026)

SeaStar Medical Holding's (ICU) quarterly Net Equity Issued and Repurchased came in at $329000.0 in Q1 2026, down 94.02% YoY from $5.5 million in Q1 2025, and down 81.61% on a QoQ basis from $1.8 million in Q4 2025.

SeaStar Medical Holding (ICU) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

SeaStar Medical Holding (ICU) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $329000.0 in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased fell 94.02% year-over-year to $329000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 million (up 210.11% YoY) and the FY2025 annual result came in at $16.1 million, down 7.54% from the prior year.
  • Net Equity Issued and Repurchased retreated to $329000.0 in Q1 2026, from $1.8 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.6 million in Q3 2025 to a low of -$51000.0 in Q2 2024.
  • A 4-year average of $2.5 million and a median of $1.1 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased slumped 192.73% — and 2025, when it jumped 13433.33%.
  • Tracing ICU's Net Equity Issued and Repurchased over 4 years: stood at $3.5 million in 2023, then slumped by 97.11% to $100000.0 in 2024, then jumped by 1689.0% to $1.8 million in 2025, then plunged by 81.61% to $329000.0 in 2026.
  • The last three Net Equity Issued and Repurchased figures came in at $329000.0 (Q1 2026), $1.8 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00 810,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 810,000.00
Jun 30, 2026 810,000.00
Mar 31, 2026 329,000.00
Mar 31, 2026 329,000.00
Dec 31, 2025 1.79 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 8.60 Mn
Sep 30, 2025 8.60 Mn
Jun 30, 2025 6.80 Mn
Jun 30, 2025 6.80 Mn
Mar 31, 2025 5.50 Mn
Mar 31, 2025 5.50 Mn
Dec 31, 2024 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 -51,000.00
Jun 30, 2024 -51,000.00
Mar 31, 2024 4.54 Mn
Mar 31, 2024 4.54 Mn